The global therapeutic drug monitoring market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is driven by factors such as increasing prevalence of chronic diseases and rising demand for personalized medicine. Therapeutic drug monitoring helps in determining the concentration levels of drugs in the body and helps in identifying any potential adverse effects or toxicity that may arise due to excessive dosage or prolonged use. Therapeutic drug monitoring also helps in determining whether a patient has been taking their medication as prescribed, which can help with compliance rates and adherence to treatment plans.
The global therapeutic drug monitoring market is segmented on the basis of type, application, and region. On the basis of type, it is classified into chemiluminescence immunoassay (CLIA), fluorescence immunoassay (FPIA), radioimmunoassay (RIA), colorimetric immunoassays, therapeutic drug monitoring assays; on the basis of application it includes antiepileptic drugs, immunosuppressant drugs, antitumor drugs psychotropic drugs antibiotics antifungal cardiovascular drugs; on the basis of region it includes North America Latin America Europe Asia Pacific Middle East & Africa.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is driving the growth of the Theraputic Drug Monitorings market.
- Increasing number of hospitalizations due to chronic diseases is also driving the growth of the Theraputic Drug Monitorings market.
- The increasing number of clinical trials for new drugs and therapies are also driving the growth in this market.
- The increasing demand for personalized medicine will drive this market.
Industry Growth Insights published a new data on “Theraputic Drug Monitorings Market”. The research report is titled “Theraputic Drug Monitorings Market research by Types (Chemiluminescence Immunoassay (CLIA), Fluorescence Immunoassay (FPIA), Radioimmunoassay (RIA), Colorimetric Immunoassay, Other Immunoassays, Theraputic Drug Monitoring), By Applications (Antiepileptic Drugs, Immunosuppressant, Antitumor Drugs, Psychotropic Drugs, Antibiotic, Antifungal, Cardiovascular Drugs, Antiasthmatic, Others), By Players/Companies Roche AG, Siemens Healthineers, Thermo Fisher Scientific, Beckman Coulter, Agilent Technologies, BioMérieux, Sekisui Medical, DiaSorin, Fujirebio, Grifols, Ortho-Clinical Diagnostics, Quest Diagnostics, Sysmex, Tosoh, Chromsystems, Bio-Rad, R-Biopharm AG, ALPCO, BIOHIT Healthcare, MedTox, Wieslab, ARK Diagnostics, Probe Scientific, Omnica, Theraputic Drug Monitoring”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Theraputic Drug Monitorings Market Research Report
By Type
Chemiluminescence Immunoassay (CLIA), Fluorescence Immunoassay (FPIA), Radioimmunoassay (RIA), Colorimetric Immunoassay, Other Immunoassays, Theraputic Drug Monitoring
By Application
Antiepileptic Drugs, Immunosuppressant, Antitumor Drugs, Psychotropic Drugs, Antibiotic, Antifungal, Cardiovascular Drugs, Antiasthmatic, Others
By Companies
Roche AG, Siemens Healthineers, Thermo Fisher Scientific, Beckman Coulter, Agilent Technologies, BioMérieux, Sekisui Medical, DiaSorin, Fujirebio, Grifols, Ortho-Clinical Diagnostics, Quest Diagnostics, Sysmex, Tosoh, Chromsystems, Bio-Rad, R-Biopharm AG, ALPCO, BIOHIT Healthcare, MedTox, Wieslab, ARK Diagnostics, Probe Scientific, Omnica, Theraputic Drug Monitoring
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Theraputic Drug Monitorings Market Report Segments:
The global Theraputic Drug Monitorings market is segmented on the basis of:
Types
Chemiluminescence Immunoassay (CLIA), Fluorescence Immunoassay (FPIA), Radioimmunoassay (RIA), Colorimetric Immunoassay, Other Immunoassays, Theraputic Drug Monitoring
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Antiepileptic Drugs, Immunosuppressant, Antitumor Drugs, Psychotropic Drugs, Antibiotic, Antifungal, Cardiovascular Drugs, Antiasthmatic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche AG
- Siemens Healthineers
- Thermo Fisher Scientific
- Beckman Coulter
- Agilent Technologies
- BioMérieux
- Sekisui Medical
- DiaSorin
- Fujirebio
- Grifols
- Ortho-Clinical Diagnostics
- Quest Diagnostics
- Sysmex
- Tosoh
- Chromsystems
- Bio-Rad
- R-Biopharm AG
- ALPCO
- BIOHIT Healthcare
- MedTox
- Wieslab
- ARK Diagnostics
- Probe Scientific
- Omnica
- Theraputic Drug Monitoring
Highlights of The Theraputic Drug Monitorings Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chemiluminescence Immunoassay (CLIA)
- Fluorescence Immunoassay (FPIA)
- Radioimmunoassay (RIA)
- Colorimetric Immunoassay
- Other Immunoassays
- Theraputic Drug Monitoring
- By Application:
- Antiepileptic Drugs
- Immunosuppressant
- Antitumor Drugs
- Psychotropic Drugs
- Antibiotic
- Antifungal
- Cardiovascular Drugs
- Antiasthmatic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Theraputic Drug Monitorings Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Theraputic Drug Monitoring (TDM) is a process by which healthcare professionals monitor the effects of medications on patients. TDM can help to ensure that patients are receiving the correct dose of medication and that side effects are being monitored.
Some of the key players operating in the theraputic drug monitorings market are Roche AG, Siemens Healthineers, Thermo Fisher Scientific, Beckman Coulter, Agilent Technologies, BioMƒÂ©rieux, Sekisui Medical, DiaSorin, Fujirebio, Grifols, Ortho-Clinical Diagnostics, Quest Diagnostics, Sysmex, Tosoh, Chromsystems, Bio-Rad, R-Biopharm AG, ALPCO, BIOHIT Healthcare, MedTox, Wieslab, ARK Diagnostics, Probe Scientific, Omnica, Theraputic Drug Monitoring.
The theraputic drug monitorings market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Theraputic Drug Monitorings Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Theraputic Drug Monitorings Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Theraputic Drug Monitorings Market - Supply Chain
4.5. Global Theraputic Drug Monitorings Market Forecast
4.5.1. Theraputic Drug Monitorings Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Theraputic Drug Monitorings Market Size (000 Units) and Y-o-Y Growth
4.5.3. Theraputic Drug Monitorings Market Absolute $ Opportunity
5. Global Theraputic Drug Monitorings Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Theraputic Drug Monitorings Market Size and Volume Forecast by Type
5.3.1. Chemiluminescence Immunoassay (CLIA)
5.3.2. Fluorescence Immunoassay (FPIA)
5.3.3. Radioimmunoassay (RIA)
5.3.4. Colorimetric Immunoassay
5.3.5. Other Immunoassays
5.3.6. Theraputic Drug Monitoring
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Theraputic Drug Monitorings Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Theraputic Drug Monitorings Market Size and Volume Forecast by Application
6.3.1. Antiepileptic Drugs
6.3.2. Immunosuppressant
6.3.3. Antitumor Drugs
6.3.4. Psychotropic Drugs
6.3.5. Antibiotic
6.3.6. Antifungal
6.3.7. Cardiovascular Drugs
6.3.8. Antiasthmatic
6.3.9. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Theraputic Drug Monitorings Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Theraputic Drug Monitorings Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Theraputic Drug Monitorings Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Theraputic Drug Monitorings Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Theraputic Drug Monitorings Demand Share Forecast, 2019-2026
9. North America Theraputic Drug Monitorings Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Theraputic Drug Monitorings Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Theraputic Drug Monitorings Market Size and Volume Forecast by Application
9.4.1. Antiepileptic Drugs
9.4.2. Immunosuppressant
9.4.3. Antitumor Drugs
9.4.4. Psychotropic Drugs
9.4.5. Antibiotic
9.4.6. Antifungal
9.4.7. Cardiovascular Drugs
9.4.8. Antiasthmatic
9.4.9. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Theraputic Drug Monitorings Market Size and Volume Forecast by Type
9.7.1. Chemiluminescence Immunoassay (CLIA)
9.7.2. Fluorescence Immunoassay (FPIA)
9.7.3. Radioimmunoassay (RIA)
9.7.4. Colorimetric Immunoassay
9.7.5. Other Immunoassays
9.7.6. Theraputic Drug Monitoring
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Theraputic Drug Monitorings Demand Share Forecast, 2019-2026
10. Latin America Theraputic Drug Monitorings Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Theraputic Drug Monitorings Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Theraputic Drug Monitorings Market Size and Volume Forecast by Application
10.4.1. Antiepileptic Drugs
10.4.2. Immunosuppressant
10.4.3. Antitumor Drugs
10.4.4. Psychotropic Drugs
10.4.5. Antibiotic
10.4.6. Antifungal
10.4.7. Cardiovascular Drugs
10.4.8. Antiasthmatic
10.4.9. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Theraputic Drug Monitorings Market Size and Volume Forecast by Type
10.7.1. Chemiluminescence Immunoassay (CLIA)
10.7.2. Fluorescence Immunoassay (FPIA)
10.7.3. Radioimmunoassay (RIA)
10.7.4. Colorimetric Immunoassay
10.7.5. Other Immunoassays
10.7.6. Theraputic Drug Monitoring
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Theraputic Drug Monitorings Demand Share Forecast, 2019-2026
11. Europe Theraputic Drug Monitorings Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Theraputic Drug Monitorings Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Theraputic Drug Monitorings Market Size and Volume Forecast by Application
11.4.1. Antiepileptic Drugs
11.4.2. Immunosuppressant
11.4.3. Antitumor Drugs
11.4.4. Psychotropic Drugs
11.4.5. Antibiotic
11.4.6. Antifungal
11.4.7. Cardiovascular Drugs
11.4.8. Antiasthmatic
11.4.9. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Theraputic Drug Monitorings Market Size and Volume Forecast by Type
11.7.1. Chemiluminescence Immunoassay (CLIA)
11.7.2. Fluorescence Immunoassay (FPIA)
11.7.3. Radioimmunoassay (RIA)
11.7.4. Colorimetric Immunoassay
11.7.5. Other Immunoassays
11.7.6. Theraputic Drug Monitoring
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Theraputic Drug Monitorings Demand Share, 2019-2026
12. Asia Pacific Theraputic Drug Monitorings Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Theraputic Drug Monitorings Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Theraputic Drug Monitorings Market Size and Volume Forecast by Application
12.4.1. Antiepileptic Drugs
12.4.2. Immunosuppressant
12.4.3. Antitumor Drugs
12.4.4. Psychotropic Drugs
12.4.5. Antibiotic
12.4.6. Antifungal
12.4.7. Cardiovascular Drugs
12.4.8. Antiasthmatic
12.4.9. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Theraputic Drug Monitorings Market Size and Volume Forecast by Type
12.7.1. Chemiluminescence Immunoassay (CLIA)
12.7.2. Fluorescence Immunoassay (FPIA)
12.7.3. Radioimmunoassay (RIA)
12.7.4. Colorimetric Immunoassay
12.7.5. Other Immunoassays
12.7.6. Theraputic Drug Monitoring
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Theraputic Drug Monitorings Demand Share, 2019-2026
13. Middle East & Africa Theraputic Drug Monitorings Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Theraputic Drug Monitorings Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Theraputic Drug Monitorings Market Size and Volume Forecast by Application
13.4.1. Antiepileptic Drugs
13.4.2. Immunosuppressant
13.4.3. Antitumor Drugs
13.4.4. Psychotropic Drugs
13.4.5. Antibiotic
13.4.6. Antifungal
13.4.7. Cardiovascular Drugs
13.4.8. Antiasthmatic
13.4.9. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Theraputic Drug Monitorings Market Size and Volume Forecast by Type
13.7.1. Chemiluminescence Immunoassay (CLIA)
13.7.2. Fluorescence Immunoassay (FPIA)
13.7.3. Radioimmunoassay (RIA)
13.7.4. Colorimetric Immunoassay
13.7.5. Other Immunoassays
13.7.6. Theraputic Drug Monitoring
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Theraputic Drug Monitorings Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Theraputic Drug Monitorings Market: Market Share Analysis
14.2. Theraputic Drug Monitorings Distributors and Customers
14.3. Theraputic Drug Monitorings Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche AG
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Siemens Healthineers
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Thermo Fisher Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Beckman Coulter
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Agilent Technologies
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. BioMérieux
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sekisui Medical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. DiaSorin
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Fujirebio
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Grifols
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Ortho-Clinical Diagnostics
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Quest Diagnostics
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Sysmex
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Tosoh
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Chromsystems
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Bio-Rad
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
&n
